CompletedNCT01552837
Brain and Hippocampal Changes During Quetiapine Treatment in Bipolarity
About this title
Read the official source — NCT01552837Medication studyAges 18–55Germany
Understand this study
Who was this study for?
Listed age limits: 18 years to 55 years.
- Listed locations
- AachenSee all locations and recruitment
Study information
Study start dateDecember 2007
- Recruitment status
- Completed
- Enrollment listed in the registry
- 33
- Sponsor
- RWTH Aachen University
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Locations
- Germany
- Age range
- From 18 Years to 55 Years
- Official registry ID
- NCT01552837
- Official title
Show the full official title
Effects of Quetiapine on Ultrastructural Hippocampal and Neurochemical Changes in Patients With Bipolar Disorder: Searching for Antidepressant and Mood Stabilising Neurophysiology
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Aachen
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is RWTH Aachen University, a university.
Did this study involve medication?
Yes. The study involved medication, including Seroquel.
Who was this study for?
Listed age limits: 18 years to 55 years.
